Marissa Lawrence

636 total citations
6 papers, 194 citations indexed

About

Marissa Lawrence is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marissa Lawrence has authored 6 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marissa Lawrence's work include Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (2 papers). Marissa Lawrence is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (2 papers). Marissa Lawrence collaborates with scholars based in United States. Marissa Lawrence's co-authors include Waganesh A. Zeleke, Tammy L. Hughes, Xiaohan Chen, Zhe Ji, Ann Huang, Michael L. Cheng, Mizuki Nishino, Joao V. Alessi, Mark M. Awad and Gonzalo Recondo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Psychology.

In The Last Decade

Marissa Lawrence

5 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marissa Lawrence United States 4 85 73 71 68 35 6 194
Sarah I. Mossad Canada 10 112 1.3× 101 1.4× 33 0.5× 8 0.1× 17 0.5× 18 324
Shimeng Wang China 5 53 0.6× 17 0.2× 25 0.4× 68 1.0× 10 0.3× 24 235
Chiou-Miin Wang United States 9 103 1.2× 11 0.2× 68 1.0× 41 0.6× 30 0.9× 11 329
Andrew Chandler United States 5 19 0.2× 34 0.5× 37 0.5× 66 1.0× 16 0.5× 28 254
G Stella Italy 7 28 0.3× 76 1.0× 42 0.6× 79 1.2× 3 0.1× 17 260
Sarah E. James United States 10 28 0.3× 10 0.1× 142 2.0× 61 0.9× 31 0.9× 23 359
Rebecca A. Marks United States 12 13 0.2× 123 1.7× 101 1.4× 38 0.6× 6 0.2× 32 368
A.R.M. Wilson United Kingdom 6 81 1.0× 90 1.2× 26 0.4× 86 1.3× 3 0.1× 17 292
Cristina Saavedra Spain 8 10 0.1× 97 1.3× 57 0.8× 104 1.5× 7 0.2× 36 249
San‐Duk Yang South Korea 7 68 0.8× 91 1.2× 45 0.6× 94 1.4× 10 0.3× 15 327

Countries citing papers authored by Marissa Lawrence

Since Specialization
Citations

This map shows the geographic impact of Marissa Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marissa Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marissa Lawrence more than expected).

Fields of papers citing papers by Marissa Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marissa Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marissa Lawrence. The network helps show where Marissa Lawrence may publish in the future.

Co-authorship network of co-authors of Marissa Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Marissa Lawrence. A scholar is included among the top collaborators of Marissa Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marissa Lawrence. Marissa Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Lawrence, Marissa, Pablo Martínez, Tristan Shaffer, et al.. (2021). SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping. JTO Clinical and Research Reports. 2(4). 100151–100151. 2 indexed citations
2.
Ricciuti, Biagio, Greg Jones, Mariano Severgnini, et al.. (2021). Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC). Journal for ImmunoTherapy of Cancer. 9(3). e001504–e001504. 108 indexed citations
3.
Lindpaintner, Klaus, Michael L. Cheng, Jillian M. Prendergast, et al.. (2021). 30 Blood-based glycoprotein signatures in advanced non-small-cell lung carcinoma (NSCLC) receiving first-line immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 9(Suppl 2). A35–A35. 3 indexed citations
4.
Ricciuti, Biagio, Joao V. Alessi, Yvonne Y. Li, et al.. (2021). DNMT3A mutation to identify a subset of non-small cell lung cancers with increased sensitivity to PD-(L)1 blockade.. Journal of Clinical Oncology. 39(15_suppl). 9113–9113. 3 indexed citations
6.
Huang, Ann, Tammy L. Hughes, Marissa Lawrence, et al.. (2017). Understanding the Self in Individuals with Autism Spectrum Disorders (ASD): A Review of Literature. Frontiers in Psychology. 8. 1422–1422. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026